The Pre-Treatment C-Reactive Protein Represents a Prognostic Factor in Patients with Oral and Oropharyngeal Cancer Treated with Radiotherapy

The Pre-Treatment C-Reactive Protein Represents a Prognostic Factor in Patients with Oral and Oropharyngeal Cancer Treated with Radiotherapy

The purpose of the present study was to evaluate the prognostic significance of the pre- treatment C-reactive protein (CRP) level in a cohort of 503 patients with oral and oropharyngeal cancer treated at a tertiary academic center between 2000 and 2017. Cancer-specific survival (CSS), overall surviv...

Full description

Bibliographic Details
Main Authors: Olivia Knittelfelder, Daniela Delago, Gabriele Jakse, Katarzyna Lukasiak, Eva-Maria Thurner, Dietmar Thurnher, Martin Pichler, Wilfried Renner, Heidi Stranzl-Lawatsch, Tanja Langsenlehner
Format: Article
Language:English
Published: MDPI AG 2020-03-01
Series:Cancers
Subjects:
oral and oropharyngeal cancer
biomarker
inflammation
c- reactive protein (crp)
prognostic factor
outcome
Online Access:https://www.mdpi.com/2072-6694/12/3/626

Internet

https://www.mdpi.com/2072-6694/12/3/626

Similar Items